XML 137 R54.htm IDEA: XBRL DOCUMENT v2.4.0.8
Shareholders' Equity - Additional Information (Detail) (USD $)
12 Months Ended 12 Months Ended 12 Months Ended
Jun. 28, 2013
Jun. 29, 2012
Jul. 01, 2011
Nov. 08, 2012
Nov. 07, 2012
Jun. 28, 2013
Restricted Stock [Member]
Jun. 28, 2013
Restricted Stock Units (RSUs) [Member]
Jun. 29, 2012
Restricted Stock Units (RSUs) [Member]
Jul. 01, 2011
Restricted Stock Units (RSUs) [Member]
Jul. 02, 2010
Restricted Stock Units (RSUs) [Member]
Sep. 13, 2012
Stock Repurchase Program [Member]
May 21, 2012
Stock Repurchase Program [Member]
Jun. 28, 2013
Minimum [Member]
Jun. 28, 2013
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Common stock remain outstanding and exercisable under prior stock option plan for purchase 194,409                          
Outstanding restricted stock or other awards           0 3,600,000 3,700,000 3,100,000 3,100,000        
Options granted under the Prior Stock Plans expire                         5 years 10 years
Vesting periods of RSUs                         1 year 5 years
Authorized number of share of common stock for awards grant under Performance Incentive Plan 48,800,000                          
Share issued in respect of any other type of award granted under the plan       1.72 1.35                  
Eligible employee payroll deduction amount for ESPP Up to 10%                          
Percentage of market value for purchases with in ESPP At 95%                          
Employee Stock Purchase Plan offering period 24 months                          
Expenses on stock-based compensation $ 88,000,000 $ 57,000,000 $ 37,000,000                      
Stock-based compensation expense tax benefit 25,000,000 12,000,000 8,000,000                      
Total compensation cost related to unvested stock options and ESPP rights issued 105,000,000                          
Weighted average service period 2 years 2 months 12 days                          
Restricted stock number of share granted             1,700,000 1,600,000 1,000,000          
Share Based payment award equity instruments other than options aggregate market value             74,000,000              
Forfeiture rate of restricted stock unit valuation assumption 2.00% 2.40% 1.80%                      
Expense related to the vesting of Restricted Stock unit awards 52,000,000 35,000,000 32,000,000                      
Tax benefit realized related to RSU 14,000,000 10,000,000 12,000,000                      
Unamortized fair value of all unvested Restricted Stock Unit awards 70,000,000                          
Weighted average vesting period 1 year 4 months 24 days                          
Employee termination benefits and other charges expense 5,000,000                          
Recognized in expenses related to adjustment to market value and vesting of SARs assumed 46,000,000                          
Benefit related to adjustments to market value and vesting of SARs assumed   7,000,000                        
Tax benefit realized related to SARs 4,000,000                          
Total liability related to SARs 46,000,000                          
Total compensation cost related to unvested SARs 11,000,000                          
Total compensation cost, weighted average service period 9 months 18 days                          
Options outstanding to purchase shares with exercise price below company stock price 11,900,000                          
Options outstanding to purchase shares with exercise price below company stock price, intrinsic value 389,000,000                          
Aggregate intrinsic value of options exercised under the Company's stock option plan 211,000,000 53,000,000 25,000,000                      
Aggregate value of restricted stock awards vested 71,000,000 41,000,000 23,000,000                      
Grant-date fair value of the shares underlying the RSU awards 74,000,000 71,000,000 26,000,000                      
Number of assumed SARs outstanding 1,000,000                          
Stock Appreciation Right outstanding, weighted average exercise price $ 7.90                          
Weighted average expected term of the Company's stock options 4 years 4 years 10 months 24 days 4 years 8 months 12 days                      
Additional common stock authorized for repurchase                     1,500,000,000 1,500,000,000    
Company repurchased shares of its common stock 19,000,000                          
Repurchase of common stock 842,000,000 604,000,000 50,000,000                      
Remaining amount available under repurchase program 2,000,000,000                          
Cash dividends declared per share $ 1.00                          
Total common stock dividends 240,000,000                          
Common stock dividends paid $ 181,000,000